TrialEBioMedicine2016
Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study.
David K Packham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
99 papers cite itlatest 60 shown
this paperpooled ittrialcites it